TOUR

Tuniu Corporation
NasdaqCMUSDEQUITY Consumer Cyclical DELAYED
Last price
5.01
▲ 0.08 (1.62%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
4.93
Day high
5.01
Day low
4.94
Volume
4.51K
Market cap
$54.43M
P/E (TTM)
19.27
52W range
4.53 – 9.47

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-0.20% -2.1%
1M
-0.60% -1.8%
3M
+1.62% -2.9%
6M
-20.48% -38.7%
YTD
-19.19% -33.4%
1Y
-47.54% -64.0%
3Y
-58.25% -140.5%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on TOUR open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
25.78K
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
May 8, 26
XU LIANGJIE
Director
— 85 — Direct
May 8, 26
CHENG HAIJIN
Director
— 45 — Direct
Apr 9, 26
XU LIANGJIE
Director
— 833 — Direct
Apr 9, 26
CHENG HAIJIN
Director
— 416 — Direct
Mar 31, 26
ANQIANG CHEN
Officer
BUY 15.50K $11.99K Direct
Mar 24, 26
DUNDE YU
Chief Executive Officer
BUY 37.90K $27.12K Direct
Mar 23, 26
ANQIANG CHEN
Officer
BUY 19.60K $14.25K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

4 reporting
NameRelationShares heldLatest
ANQIANG CHEN
Officer 68.20K Purchase
CHENG HAIJIN
Director 2.00K Conversion of Exercise of derivative security
DUNDE YU
Chief Executive Officer 3.74M Purchase
XU LIANGJIE
Director 4.00K Conversion of Exercise of derivative security

Fundamentals

TTM · reported
Market cap$54.43M
Enterprise value$-992.05M
Revenue (TTM)$597.11M
Gross profit$329.64M
EBITDA$28.04M
Net income$22.67M
EPS (TTM)$0.26
Free cash flow—
Total cash$977.49M
Total debt$4.62M
Book value / share$13.94
Shares outstanding10.28M
Float4.06M
Short % of float33.54%
Dividend yield23.89%
Beta (5Y)0.35

Valuation & profitability ratios

Account required
Trailing P/E19.27
Forward P/E16.88
PEG ratio—
Price / sales—
Price / book0.36
EV / revenue-1.66
EV / EBITDA-35.38
Gross margin55.21%
Operating margin-4.38%
Profit margin3.80%
Return on equity2.36%
Return on assets0.83%
Debt / equity0.54
Current ratio1.94
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $577.97M$513.62M$441.27M$183.62M +12.5%
Operating revenue $493.48M$407.46M$333.36M$70.31M +21.1%
Cost of revenue $242.99M$155.59M$147.58M$94.07M +56.2%
Gross profit $334.98M$358.03M$293.69M$89.55M -6.4%
Research & development $58.98M$52.68M$56.97M$50.80M +12.0%
Selling, general & admin $265.73M$267.98M$230.93M$212.55M -0.8%
Total operating expense $323.75M$294.77M$280.89M$187.67M +9.8%
Operating income $11.23M$63.26M$12.80M-$98.11M -82.2%
Net interest income $23.75M$16.55M$2.16M$22.27M +43.5%
Pre-tax income $30.50M$83.05M-$99.08M-$204.02M -63.3%
Tax provision $1.43M$837.00K$1.44M-$731.00K +70.3%
Net income $31.13M$77.17M-$99.29M-$193.38M -59.7%
Net income to common $31.13M$77.17M-$99.29M-$193.38M -59.7%
Basic EPS 2.706.30-8.10-15.60 -57.1%
Diluted EPS 2.706.30-8.10-15.60 -57.1%
EBIT $32.52M$86.37M-$95.55M-$199.11M -62.3%
EBITDA $47.52M$103.50M-$65.87M-$160.94M -54.1%
Basic shares 11.36M12.05M12.38M12.37M -5.7%
Diluted shares 11.43M12.12M12.38M12.37M -5.7%

Options analytics

Account required
Put / call volume
0.44
Call-heavy session
Put / call open interest
0.00
Positioning, not flow
Max pain
2.50
-50.1% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
+0.8%
Puts bid over calls
Call volume
9
Contracts, this expiry
Put volume
4
Contracts, this expiry
Heaviest call OI
2.50
17 contracts
Heaviest put OI
5.00
0 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter — — $0 —
Next quarter — — $0 —
Current year 1.88 1 $606.87M +5.0%
Next year 1.99 1 $625.08M +3.0%

Analyst targets & ownership

Account required
Mean target$8.24
High target$8.24
Low target$8.24
Implied upside64.52%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders0.24%
Held by institutions5.57%
Institutions holding15
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
5.03
-0.30% from price
SMA 20
5.07
-1.14% from price
SMA 50
5.03
-0.37% from price
SMA 100
5.14
-2.52% from price
SMA 200
5.98
-16.16% from price
EMA 12
5.02
-0.28% from price
EMA 26
5.04
-0.53% from price
EMA 50
5.07
-1.22% from price
RSI (14)
48.6
Neutral
MACD (12,26,9)
-0.01
Hist -0.02
ATR (14)
0.14
2.82% of price
Realised vol 30D
35.6%
Annualised
Bollinger upper
5.26
20, 2σ
Bollinger lower
4.88
20, 2σ
50 / 200 cross
Death
5.03 vs 5.98
Trend bias
Below 200
-16.16%

Options chain

Account required
Expiry
Spot 5.01
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.88
Less volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
35.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-51.3%
Peak to trough
Max drawdown 5Y
-84.1%
Peak to trough
ATR 14
0.14
2.82% of price
Beta (reported)
0.35
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
102.82K
Prior 29.27K
Change vs prior
+251.3%
Shorts adding
% of float
33.54%
Heavily shorted
% of shares out
0.95%
Against total outstanding
Days to cover
13.2
Crowded exit
Float
4.06M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

12 on file
DateFirm ActionFromTo
Feb 24, 17 Morgan Stanley UPGRADE Equal-Weight Overweight
Jan 12, 17 Credit Suisse UPGRADE Neutral Outperform
May 20, 16 Deutsche Bank INITIATED — Buy
Apr 26, 16 Morgan Stanley DOWNGRADE Overweight Equal-Weight
Dec 8, 15 Morgan Stanley UPGRADE Equal-Weight Overweight
May 26, 15 Credit Suisse DOWNGRADE Outperform Neutral
May 26, 15 Credit Suisse DOWNGRADE Outperform Neutral
Apr 20, 15 Summit Insights Group INITIATED — Buy
Feb 3, 15 Morgan Stanley UPGRADE Equal-Weight Overweight
Nov 12, 14 Morgan Stanley MAINTAINED — Equal-Weight
Aug 13, 14 Credit Suisse DOWNGRADE Outperform Neutral
Jun 18, 14 Morgan Stanley INITIATED — Equal-Weight

Dividends & splits

Declared · from the issuer
Forward rate$1.20 / yr
Forward yield23.89%
5-year avg yield—
Payout ratio467.57%
Ex-dividend dateMay 4, 2026
Next pay dateMay 20, 2026
Last split1:10
Split dateApr 22, 2026

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.